Investigation into the genetics of fetal congenital lymphatic anomalies

Congenital lymphatic anomalies (LAs) arise due to defects in lymphatic development and often present in utero as pleural effusion, chylothorax, nuchal and soft tissue edema, ascites, or hydrops. Many LAs are caused by single nucleotide variants, which are not detected on routine prenatal testing.

[1]  C. Shawber,et al.  Propranolol Therapy for Congenital Chylothorax. , 2023, Pediatrics.

[2]  E. Zackai,et al.  Genetics etiologies and genotype phenotype correlations in a cohort of individuals with central conducting lymphatic anomaly , 2022, European Journal of Human Genetics.

[3]  A. Gharavi,et al.  Diagnostic sequencing to support genetically stratified medicine in a tertiary care setting. , 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

[4]  L. Garçon,et al.  PIEZO1‐gene gain‐of‐function mutations with lower limb lymphedema onset in an adult: Clinical, scintigraphic, and noncontrast magnetic resonance lymphography findings , 2021, American journal of medical genetics. Part A.

[5]  M. Hurles,et al.  Fetal exome sequencing for isolated increased nuchal translucency: should we be doing it? , 2021, BJOG : an international journal of obstetrics and gynaecology.

[6]  Ying Jiang,et al.  Case Report: Whole Exome Sequencing Revealed Two Novel Mutations of PIEZO1 Implicated in Nonimmune Hydrops Fetalis , 2021, Frontiers in Genetics.

[7]  K. Alitalo,et al.  Lymphatic Malformations: Genetics, Mechanisms and Therapeutic Strategies. , 2021, Circulation research.

[8]  R. Helaers,et al.  KRAS-driven model of Gorham-Stout disease effectively treated with trametinib , 2021, JCI insight.

[9]  J. Walia,et al.  Congenital Chylothorax and Hydrops Fetalis: A Novel Neonatal Presentation of RASA1 Mutation , 2021, Pediatrics.

[10]  I. Iacobas,et al.  How we approach the diagnosis and management of complex lymphatic anomalies , 2020, Pediatric blood & cancer.

[11]  M. D. Di Gregorio,et al.  RECURRENT PRENATAL PIEZO1-RELATED LYMPHATIC DYSPLASIA: EXPANDING MOLECULAR AND ULTRASOUND FINDINGS. , 2020, European journal of medical genetics.

[12]  H. Hakonarson,et al.  Severe Lymphatic Disorder Resolved With MEK Inhibition in a Patient With Noonan Syndrome and SOS1 Mutation , 2020, Pediatrics.

[13]  Stephan J Sanders,et al.  Exome Sequencing for Prenatal Diagnosis in Nonimmune Hydrops Fetalis. , 2020, The New England journal of medicine.

[14]  M. Baglivo,et al.  TIE1 as a Candidate Gene for Lymphatic Malformations with or without Lymphedema , 2020, International journal of molecular sciences.

[15]  Ziyou Yu,et al.  Dysfunction of dermal initial lymphatics of the arm and upper body quadrant causes congenital arm lymphedema. , 2020, Journal of vascular surgery. Venous and lymphatic disorders.

[16]  David B. Goldstein,et al.  ATAV: a comprehensive platform for population-scale genomic analyses , 2020, bioRxiv.

[17]  S. Mansour,et al.  Update and audit of the St George’s classification algorithm of primary lymphatic anomalies: a clinical and molecular approach to diagnosis , 2020, Journal of Medical Genetics.

[18]  D. Adams,et al.  Multidisciplinary guidelines for initial evaluation of complicated lymphatic anomalies—expert opinion consensus , 2020, Pediatric blood & cancer.

[19]  R. Erickson,et al.  Sex‐limited penetrance of lymphedema to females with CELSR1 haploinsufficiency: A second family , 2019, Clinical genetics.

[20]  S. Maitz,et al.  Increasing evidence of hereditary lymphedema caused by CELSR1 loss‐of‐function variants , 2019, American journal of medical genetics. Part A.

[21]  T. Sparks,et al.  A system‐based approach to the genetic etiologies of non‐immune hydrops fetalis , 2019, Prenatal diagnosis.

[22]  V. Calcaterra,et al.  PIEZO1 Hypomorphic Variants in Congenital Lymphatic Dysplasia Cause Shape and Hydration Alterations of Red Blood Cells , 2019, Front. Physiol..

[23]  S. Morris,et al.  Cervical lymphatic malformations: Prenatal characteristics and ex utero intrapartum treatment , 2019, Prenatal diagnosis.

[24]  V. Jobanputra,et al.  Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study , 2019, The Lancet.

[25]  C. Bénéteau,et al.  Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients , 2019, Haematologica.

[26]  P. Lapunzina,et al.  Somatic activating mutations in PIK3CA cause generalized lymphatic anomaly , 2018, The Journal of experimental medicine.

[27]  L. Laurent,et al.  Nonimmune hydrops fetalis: identifying the underlying genetic etiology , 2018, Genetics in Medicine.

[28]  Joshua L. Deignan,et al.  Identification of novel PIEZO1 variants using prenatal exome sequencing and correlation to ultrasound and autopsy findings of recurrent hydrops fetalis , 2018, American journal of medical genetics. Part A.

[29]  M. Caron,et al.  hCALCRL mutation causes autosomal recessive nonimmune hydrops fetalis with lymphatic dysplasia , 2018, The Journal of experimental medicine.

[30]  L. Prantl,et al.  PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations , 2018, PloS one.

[31]  A. Berenstein,et al.  Expanding the clinical and molecular findings in RASA1 capillary malformation-arteriovenous malformation , 2018, European Journal of Human Genetics.

[32]  Donna M. Martin,et al.  Genotype–phenotype correlations in individuals with pathogenic RERE variants , 2018, Human mutation.

[33]  S. Mansour,et al.  Human phenotypes caused by PIEZO1 mutations; one gene, two overlapping phenotypes? , 2018, The Journal of physiology.

[34]  E. Eyal,et al.  Somatic NRAS mutation in patient with generalized lymphatic anomaly , 2018, Angiogenesis.

[35]  J. Kandel,et al.  Initial Experience With Propranolol Treatment of Lymphatic Anomalies: A Case Series , 2016, Pediatrics.

[36]  A. Hoischen,et al.  EPHB4 kinase–inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis , 2016, The Journal of clinical investigation.

[37]  M. Gonzalez-Garay,et al.  A novel mutation in CELSR1 is associated with hereditary lymphedema , 2016, Vascular cell.

[38]  Shin Lin,et al.  Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis , 2015, Nature Communications.

[39]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[40]  S. Chauhan,et al.  Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis. , 2015, American journal of obstetrics and gynecology.

[41]  Yujun Han,et al.  Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios , 2015, Genetics in Medicine.

[42]  M. Vikkula,et al.  Genetics of lymphatic anomalies. , 2014, The Journal of clinical investigation.

[43]  W. Chung,et al.  RASA1 Mutations and Associated Phenotypes in 68 Families with Capillary Malformation–Arteriovenous Malformation , 2013, Human mutation.

[44]  A. Kothari,et al.  The value of early recognition of fetal lymphangioma , 2013, Australasian journal of ultrasound in medicine.

[45]  M. Gonzalez-Garay,et al.  Lymphatic abnormalities are associated with RASA1 gene mutations in mouse and man , 2013, Proceedings of the National Academy of Sciences.

[46]  Kelly Schoch,et al.  Clinical application of exome sequencing in undiagnosed genetic conditions , 2012, Journal of Medical Genetics.

[47]  John Monahan,et al.  9-Cis Retinoic Acid Promotes Lymphangiogenesis and Enhances Lymphatic Vessel Regeneration: Therapeutic Implications of 9-Cis Retinoic Acid for Secondary Lymphedema , 2012, Circulation.

[48]  A. G. Gittenberger-de Groot,et al.  Aberrant lymphatic development in euploid fetuses with increased nuchal translucency including Noonan syndrome , 2011, Prenatal diagnosis.

[49]  S. Baki,et al.  Congenital Chylothorax , 2009, TheScientificWorldJournal.

[50]  S. Kuo,et al.  A recurrent ITGA9 missense mutation in human fetuses with severe chylothorax: possible correlation with poor response to fetal therapy , 2008, Prenatal diagnosis.

[51]  A. G. Gittenberger-de Groot,et al.  Jugular Lymphatic Maldevelopment in Turner Syndrome and Trisomy 21: Different Anomalies Leading to Nuchal Edema , 2008, Reproductive Sciences.

[52]  M. Vikkula,et al.  Hydrops fetalis: an unusual prenatal presentation of hereditary congenital lymphedema , 2005, Prenatal diagnosis.

[53]  E. Bawle,et al.  Nonimmune hydrops fetalis in Noonan's syndrome. , 1986, American journal of diseases of children.

[54]  F. Blei.  ISSVA Classification of Vascular Anomalies , 2017 .

[55]  S. Shvartsman,et al.  RASopathies: unraveling mechanisms with animal models , 2015, Disease Models & Mechanisms.

[56]  E. Fulcheri,et al.  Nuchal translucency and lymphatic system maldevelopment , 2009, Journal of perinatal medicine.